<rdf:RDF xmlns:rdf="http://www.openarchives.org/OAI/2.0/rdf/" xmlns:ow="http://www.ontoweb.org/ontology/1#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:ds="http://dspace.org/ds/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/rdf/ http://www.openarchives.org/OAI/2.0/rdf.xsd">
   <ow:Publication rdf:about="oai:digibug.ugr.es:10481/91181">
      <dc:title>Activity of Fosfomycin on Clinical Isolates of Campylobacter jejuni and Campylobacter coli of Enteric Origin</dc:title>
      <dc:creator>Sorlozano Puerto, Antonio</dc:creator>
      <dc:creator>Navarro Marí, José María</dc:creator>
      <dc:creator>Gutiérrez Fernández, José</dc:creator>
      <dc:date>2024-04-26T09:09:13Z</dc:date>
      <dc:date>2024-04-26T09:09:13Z</dc:date>
      <dc:date>2017-01</dc:date>
      <dc:type>info:eu-repo/semantics/article</dc:type>
      <dc:identifier>Sorlózano-Puerto A, Navarro-Marí JM, Gutiérrez-Fernández J. 2017. Activity of fosfomycin on clinical isolates of Campylobacter jejuni and Campylobacter coli of enteric origin. Antimicrob Agents Chemother 61:e02317-16. https://doi.org/10.1128/ AAC.02317-16</dc:identifier>
      <dc:identifier>https://hdl.handle.net/10481/91181</dc:identifier>
      <dc:identifier>10.1128/AAC.02317-16</dc:identifier>
      <dc:language>eng</dc:language>
      <dc:rights>http://creativecommons.org/licenses/by-nc-nd/4.0/</dc:rights>
      <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
      <dc:rights>Attribution-NonCommercial-NoDerivatives 4.0 Internacional</dc:rights>
      <dc:publisher>American Society for Microbiology</dc:publisher>
   </ow:Publication>
</rdf:RDF>